Sernova Corp logo

Sernova Corp

0
STU:PSH (Canada)  
€ 0.15 (-1.55%) Nov 8
At Loss
Market Cap:
€ 52.16M ($ 55.92M)
Enterprise V:
€ 49.20M ($ 52.75M)
Volume:
600.00
Avg Vol (2M):
7.80K
Trade In:

Business Description

Description
Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is is a scalable, implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.
Name Current Vs Industry Vs History
Cash-To-Debt 8.48
Equity-to-Asset -1.68
Debt-to-Equity -0.05
Debt-to-EBITDA -0.02
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 31.42
9-Day RSI 38.25
14-Day RSI 42.06
6-1 Month Momentum % -36.32
12-1 Month Momentum % -67.09

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.32
Quick Ratio 0.32
Cash Ratio 0.26

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.4
Shareholder Yield % -0.34
Name Current Vs Industry Vs History
ROE % -902.59
ROA % -209.05
ROIC % -2743.49
3-Year ROIIC % -18165.98
ROC (Joel Greenblatt) % -4895.2
ROCE % -832.51

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -1.91
EV-to-Forward-EBIT -2.23
EV-to-EBITDA -1.94
EV-to-Forward-EBITDA -2.23
EV-to-FCF -2.8
Earnings Yield (Greenblatt) % -52.36
FCF Yield % -33.71

Financials

STU:PSH's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sernova Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.082
Beta 0.9
Volatility % 38.7
14-Day RSI 42.06
14-Day ATR (€) 0.009736
20-Day SMA (€) 0.16299
12-1 Month Momentum % -67.09
52-Week Range (€) 0.1302 - 0.539
Shares Outstanding (Mil) 325.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sernova Corp Filings

Filing Date Document Date Form
No Filing Data

Sernova Corp Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Sernova Corp Frequently Asked Questions

What is Sernova Corp(STU:PSH)'s stock price today?
The current price of STU:PSH is €0.15. The 52 week high of STU:PSH is €0.54 and 52 week low is €0.13.
When is next earnings date of Sernova Corp(STU:PSH)?
The next earnings date of Sernova Corp(STU:PSH) is .
Does Sernova Corp(STU:PSH) pay dividends? If so, how much?
Sernova Corp(STU:PSH) does not pay dividend.

Press Release

Subject Date
No Press Release